Recombinant Follicle-Stimulating Hormone in the Treatment of Patients with History of Severe Ovarian Hyperstimulation Syndrome
- 1 March 1998
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 69 (3) , 72S-75S
- https://doi.org/10.1016/s0015-0282(97)00510-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndromeFertility and Sterility, 1995
- Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization.Fertility and Sterility, 1995
- Follicular aspiration does not protect against the development of ovarian hyperstimulation syndromeJournal of Assisted Reproduction and Genetics, 1992
- Hypersecretion of luteinising hormone, infertility, and miscarriageThe Lancet, 1990
- Ovarian Hyperstimulation SyndromeObstetrical & Gynecological Survey, 1989
- Gonadotropin therapy of female infertilityActa Endocrinologica, 1989
- Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.BMJ, 1988
- OVULATION OF A SINGLE DOMINANT FOLLICLE DURING TREATMENT WITH LOW‐DOSE PULSATILE FOLLICLE STIMULATING HORMONE IN WOMEN WITH POLYCYSTIC OVARY SYNDROMEClinical Endocrinology, 1987
- The Use of Human Gonadotropins for the Induction of Ovulation in Women with Polycystic Ovarian DiseaseFertility and Sterility, 1980
- Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin TherapyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1978